The State Pharmaceuticals Manufacturing Corp is involved in the business of manufacturing, processing, stocking, packing, repacking and marketing of drugs. Its operations are divided into five segments: Production, Quality control, Formulation Research & Development, Marketing and Other Services. Its Production segment is involved in manufacturing pharmaceutical drugs and conducting initial and in-process testing of the products. The Quality Control (QC) Department is an independent internal regulatory body of the SPMC. Its overall function includes both Quality Control and monitoring of Quality assurance processes of the organisation by implementing a total quality management system and good manufacturing practices. The Formulation R&D segment is primarily involved in the development of new products and introducing them to the current manufacturing stream, and improving existing products. The Marketing segment distributes its drugs throughout its network and also abroad, to destinations including Egypt, Myanmar, Bangladesh and other countries. Other services include its Finance, Engineering and Audit departments. Established in 1987, its headquarters are in Ratmalana, Sri Lanka.
State Pharmaceuticals Manufacturing Corporation

ROA
Governance
Profits/Losses
Governance Indicators
A systematic measure of how well this SOE is managed.
Year of the most recent Annual Report available online
Have Annual Reports for the last five years been tabled in Parliament?
Does the Annual Report include the mandatory provisions set out in the PED guidelines?
Is the Audit Clean / Qualified / Disclaimer?
Is the information pertaining to the RTI officer available on the website?
Does the SOE respond to an RTI within the timeframe specified in the Act?
Does the SOE have a website?
Does the SOE website contain sufficient organtisational details?
Does the SOE website contain tender and procurement details?
Interpratation of the indicators
Financials
Available Financial data for the last few years.
Year | Turnover (LKR) | Total Assets | Profit/Loss | Total Debt | Total Liabilities | Total Equity | Operational Profits | ROA |
---|---|---|---|---|---|---|---|---|
2020
|
7,648,000
|
Data Not Avalaible | 1,164,000 | Data Not Avalaible | Data Not Avalaible | Data Not Avalaible | Data Not Avalaible |
Data Not Avalaible
|
2019
|
5,646,878
|
Data Not Avalaible | 434,777 |
2,685,049
|
3,733,598
|
3,451,788
|
564,411
|
12.1
|
2018
|
4,621,537
|
6,229,454
|
251,262 |
2,604,320
|
3,274,177
|
2,955,277
|
308,741
|
5.4
|
2017
|
3,174,613
|
3,073,471
|
223,908 |
176,537
|
331,826
|
2,741,645
|
244,782
|
7.5
|
2016
|
2,549,000
|
2,902,000
|
262,000 | Data Not Avalaible |
343,000
|
2,560,000
|
262,000
|
9.4
|
2015
|
2,054,363
|
2,700,885
|
262,323 |
179,058
|
402,008
|
2,298,877
|
364,846
|
10.3
|
Download our datasets
Access Advocata Institute's Datasets on State Owned Enterprises